Epizyme Inc. Stock
Epizyme Inc. Stock
Epizyme Inc. dominated the market today, gaining €0.000 (5.170%).
With 1 Sell predictions and 0 Buy predictions the community sentiment towards the Epizyme Inc. stock is not clear.
Our community identified positive and negative aspects for Epizyme Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Epizyme Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Epizyme Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Epizyme Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Epizyme Inc. | 5.170% | 0.831% | -26.094% | -80.087% | -13.442% | - | - |
| Clovis Oncology Inc. | -2.720% | -7.799% | -27.875% | -62.013% | -14.399% | -90.063% | -96.229% |
| Flexion Therapeutics Inc. | -0.620% | 0.000% | 0.000% | -25.463% | 0.000% | - | - |
| Champions Oncology Inc | 0.000% | -2.113% | -8.553% | -21.469% | -2.113% | - | - |
Comments
Other discussions about Epizyme Inc. Stock
Trading Epizyme Inc.
Trading Epizyme Inc.
